Journal ArticleOPEN ACCESS

Clinical Impact of Plasma and Tissue Next-Generation Sequencing in Advanced Non-Small Cell Lung Cancer: A Real-World Experience

  • Bonanno L
  • Pavan A
  • et al.
The Oncologist (2020) 25(12) e1996-e2005
DOI: 10.1634/theoncologist.2020-0148
29Citations
Citations of this article
47Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

… the College of American Pathologists, the International Association for the Study of Lung Cancer, and the … Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors … Dabrafenib in BRAF-mutated metastatic mela- noma: A multicentre, open-label, phase 3 …

Cite

CITATION STYLE

APA

Bonanno, L., Pavan, A., Ferro, A., Calvetti, L., Frega, S., … Conte, P. (2020). Clinical Impact of Plasma and Tissue Next-Generation Sequencing in Advanced Non-Small Cell Lung Cancer: A Real-World Experience. The Oncologist, 25(12), e1996–e2005. https://doi.org/10.1634/theoncologist.2020-0148

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free